| BMY |
Bristol-Myers Squibb Company |
115.69B |
8.87% |
|
|
|
|
|
57.04 |
1.33% |
26.07% |
39.82% |
|---|
| PFE |
Pfizer Inc. |
150.97B |
7.20% |
|
|
|
|
|
26.64 |
1.29% |
28.29% |
56.47% |
|---|
| ABBV |
AbbVie Inc. |
305.03B |
7.09% |
|
|
|
|
|
172.61 |
0.61% |
25.66% |
54.79% |
|---|
| JNJ |
Johnson & Johnson |
356.69B |
6.83% |
|
|
|
|
|
148.15 |
0.76% |
19.03% |
41.70% |
|---|
| MRK |
Merck & Co., Inc. |
243.45B |
6.56% |
|
|
|
|
|
96.24 |
-1.72% |
29.23% |
82.06% |
|---|
| GILD |
Gilead Sciences, Inc. |
115.85B |
4.60% |
|
|
|
|
|
92.96 |
1.22% |
24.35% |
38.35% |
|---|
| CAH |
Cardinal Health, Inc. |
30.94B |
4.13% |
|
|
|
|
|
127.83 |
1.24% |
25.64% |
41.78% |
|---|
| VTRS |
Viatris Inc. |
13.52B |
4.05% |
|
|
|
|
|
11.33 |
0.27% |
27.64% |
37.90% |
|---|
| UTHR |
United Therapeutics Corporation |
16.43B |
3.75% |
|
|
|
|
|
367.97 |
2.52% |
31.02% |
56.75% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.34B |
3.56% |
|
|
|
|
|
121.43 |
0.21% |
27.41% |
17.79% |
|---|
| ZTS |
Zoetis Inc. |
75.58B |
3.49% |
|
|
|
|
|
167.53 |
1.29% |
29.50% |
31.91% |
|---|
| LLY |
Eli Lilly and Company |
704.72B |
3.19% |
|
|
|
|
|
742.35 |
2.29% |
36.06% |
35.13% |
|---|
| AMGN |
Amgen Inc. |
147.72B |
3.07% |
|
|
|
|
|
274.81 |
0.99% |
27.86% |
24.94% |
|---|
| BIIB |
Biogen Inc. |
20.54B |
2.90% |
|
|
|
|
|
140.98 |
0.31% |
37.19% |
62.53% |
|---|
| OGN |
Organon & Co. |
4.09B |
2.42% |
|
|
|
|
|
15.88 |
0.89% |
41.95% |
41.92% |
|---|
| CRL |
Charles River Laboratories International... |
8.68B |
2.40% |
|
|
|
|
|
169.81 |
3.86% |
44.25% |
60.61% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
74.33B |
2.34% |
|
|
|
|
|
687.80 |
0.91% |
35.86% |
61.72% |
|---|
| MEDP |
Medpace Holdings, Inc. |
10.80B |
1.86% |
|
|
|
|
|
347.52 |
3.01% |
55.02% |
55.11% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
14.77B |
1.61% |
|
|
|
|
|
145.88 |
1.83% |
39.33% |
38.71% |
|---|
| ELAN |
Elanco Animal Health Incorporated |
5.95B |
1.60% |
|
|
|
|
|
12.04 |
0.17% |
40.52% |
22.03% |
|---|
| ALKS |
Alkermes plc |
4.87B |
1.13% |
|
|
|
|
|
30.10 |
2.14% |
46.26% |
68.15% |
|---|
| EXEL |
Exelixis, Inc. |
10.40B |
1.12% |
|
|
|
|
|
36.43 |
0.64% |
34.72% |
24.39% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.12B |
1.10% |
|
|
|
|
|
55.94 |
2.08% |
36.82% |
16.72% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
3.92B |
0.95% |
|
|
|
|
|
79.30 |
0.92% |
34.44% |
40.54% |
|---|
| PRGO |
Perrigo Company plc |
3.34B |
0.95% |
|
|
|
|
|
24.45 |
2.56% |
38.19% |
31.86% |
|---|
| CORT |
Corcept Therapeutics Incorporated |
6.40B |
0.79% |
|
|
|
|
|
61.11 |
10.49% |
60.98% |
27.26% |
|---|
| TGTX |
TG Therapeutics, Inc. |
4.65B |
0.74% |
|
|
|
|
|
29.86 |
1.05% |
63.01% |
35.61% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.27B |
0.69% |
|
|
|
|
|
38.10 |
3.48% |
81.06% |
55.70% |
|---|
| ACLX |
Arcellx, Inc. |
3.60B |
0.63% |
|
|
|
|
|
66.57 |
0.14% |
43.95% |
20.66% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
13.44B |
0.63% |
|
|
|
|
|
126.50 |
0.24% |
12.02% |
5.91% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
34.18B |
0.62% |
|
|
|
|
|
264.99 |
7.60% |
33.02% |
21.33% |
|---|
| TWST |
Twist Bioscience Corporation |
3.01B |
0.60% |
|
|
|
|
|
50.45 |
6.08% |
78.88% |
50.28% |
|---|
| VCEL |
Vericel Corporation |
2.94B |
0.59% |
|
|
|
|
|
59.56 |
0.83% |
46.83% |
16.57% |
|---|
| INCY |
Incyte Corporation |
14.15B |
0.57% |
|
|
|
|
|
73.47 |
2.14% |
49.14% |
59.28% |
|---|
| ADMA |
ADMA Biologics, Inc. |
3.82B |
0.55% |
|
|
|
|
|
16.16 |
0.87% |
54.56% |
9.05% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.98B |
0.55% |
|
|
|
|
|
17.89 |
1.82% |
41.92% |
23.75% |
|---|
| ROIV |
Roivant Sciences Ltd. |
8.20B |
0.51% |
|
|
|
|
|
11.27 |
1.08% |
36.56% |
51.66% |
|---|
| EXAS |
Exact Sciences Corporation |
10.04B |
0.50% |
|
|
|
|
|
54.26 |
4.87% |
52.85% |
26.11% |
|---|
| BPMC |
Blueprint Medicines Corporation |
7.11B |
0.50% |
|
|
|
|
|
111.96 |
1.74% |
71.64% |
50.84% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.95B |
0.50% |
|
|
|
|
|
8.56 |
3.63% |
182.91% |
18.97% |
|---|
| INSM |
Insmed Incorporated |
13.73B |
0.49% |
|
|
|
|
|
76.75 |
5.85% |
45.20% |
5.57% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.16B |
0.49% |
|
|
|
|
|
116.79 |
-1.03% |
34.27% |
-1.41% |
|---|
| KRYS |
Krystal Biotech, Inc. |
4.36B |
0.45% |
|
|
|
|
|
151.55 |
2.13% |
46.30% |
38.47% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
2.83B |
0.45% |
|
|
|
|
|
43.70 |
7.61% |
68.52% |
33.05% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
11.92B |
0.44% |
|
|
|
|
|
62.53 |
1.63% |
30.53% |
24.93% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
110.19B |
0.44% |
|
|
|
|
|
427.89 |
1.40% |
30.04% |
34.00% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.16B |
0.40% |
|
|
|
|
|
32.68 |
3.98% |
47.94% |
47.62% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.68B |
0.36% |
|
|
|
|
|
30.84 |
6.64% |
84.48% |
21.79% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
3.66B |
0.34% |
|
|
|
|
|
32.87 |
0.67% |
84.95% |
18.71% |
|---|
| MYGN |
Myriad Genetics, Inc. |
1.14B |
0.26% |
|
|
|
|
|
12.57 |
1.45% |
122.23% |
70.30% |
|---|
|
US Dollar |
|
0.13% |
|
|
|
|
|
|
|
|
|
|---|